CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -59.1% | 14,281 | -5.6% | 0.03% | -52.3% |
| Q4 2021 | $171,000 | -25.0% | 15,125 | -3.3% | 0.06% | -35.0% |
| Q3 2021 | $228,000 | +18.8% | 15,636 | -4.9% | 0.10% | +26.6% |
| Q2 2021 | $192,000 | -28.6% | 16,448 | -25.4% | 0.08% | -30.7% |
| Q1 2021 | $269,000 | -0.7% | 22,053 | +1.8% | 0.11% | +1.8% |
| Q4 2020 | $271,000 | +48.9% | 21,660 | +79.6% | 0.11% | +17.9% |
| Q3 2020 | $182,000 | -45.8% | 12,061 | -12.1% | 0.10% | -40.3% |
| Q2 2020 | $336,000 | – | 13,718 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |